Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Capital Leases (2017 - 2025)

Organogenesis Holdings (ORGO) has 8 years of Capital Leases data on record, last reported at $12.8 million in Q4 2025.

  • For Q4 2025, Capital Leases rose 1681.06% year-over-year to $12.8 million; the TTM value through Dec 2025 reached $12.8 million, up 1681.06%, while the annual FY2025 figure was $12.8 million, 1681.06% up from the prior year.
  • Capital Leases reached $12.8 million in Q4 2025 per ORGO's latest filing, up from $2.1 million in the prior quarter.
  • Across five years, Capital Leases topped out at $12.8 million in Q4 2025 and bottomed at $98000.0 in Q2 2025.
  • Average Capital Leases over 4 years is $2.7 million, with a median of $1.3 million recorded in 2024.
  • Peak YoY movement for Capital Leases: tumbled 93.21% in 2021, then soared 1681.06% in 2025.
  • A 4-year view of Capital Leases shows it stood at $831000.0 in 2021, then surged by 127.2% to $1.9 million in 2023, then crashed by 61.97% to $718000.0 in 2024, then skyrocketed by 1681.06% to $12.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Leases were $12.8 million in Q4 2025, $2.1 million in Q3 2025, and $98000.0 in Q2 2025.